Zydus receives USFDA approval for ZITUVIO™ to treat adult …
Oct 20, 2023 · Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as 'Zydus') today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug...
Zydus aims to launch first new drug in US by early 2026
Feb 27 (Reuters) - India's Zydus Lifesciences (ZYDU.NS) is aiming to launch its first new drug in the United States by early 2026, looking to tap into the multi-billion dollar market for treating...
Zydus Group Latest Update, News And Press Releases - Zydus Life
08 October 2021. Zydus Cadila receives tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel. 08 October 2021. View More. Get all the latest Zydus Group information, News, Videos, Press Releases and updates here.
Zydus appoints Mr. Punit Patel as President and CEO to lead its ...
Oct 16, 2023 · Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit...
Zydus Life gets USFDA approval for Fludrocortisone Acetate …
4 days ago · Zydus Lifesciences. Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg from the United ...
India's Zydus Lifesciences beats Q3 profit estimates; approves …
Feb 9, 2024 · Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales in its domestic and overseas markets.
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for ZITUVIOTM (Sitagliptin) tablets, 25 mg, 50 mg, and 100 mg.
Zydus Lifesciences: Zydus Lifesciences Q1 results ... - The Economic Times
Aug 12, 2024 · Zydus Lifesciences reported a net profit jump of 31% to Rs 1420 crore in Q1FY25 led by robust sales growth in India and US markets. The drug maker had reported a net profit of Rs 1,087 crore in the April-June quarter of last fiscal. Revenue from …
India's Zydus Q2 profit jumps on strong domestic, US demand
Nov 7, 2023 · Indian generic drugmaker Zydus Lifesciences Ltd reported a better-than-expected 53.3% jump in quarterly profit on Tuesday, led by the strong sales in the domestic market and the United States.
Roche vs Zydus: Delhi High Court reinstates Sigrima's interim ...
5 days ago · Representative image. Mumbai: On October 16, 2024, the Division Bench of the Delhi High Court, upon hearing the appeal of Roche, has reinstated the injunction in favour of Roche.This injunction once again restrains Zydus from manufacturing, selling, or marketing Sigrima.This now reinstates the legal position previously pronounced by the Delhi High Court in its order dated July 9, 2024.